|Novartis||Investor Relations Officer||Switzerland|
How to differentiate as a potential partner on the crowded oncology playfield?
Dr. Pierre-Michel Bringer, former Investor Relations Officer with Novartis, and President of PM. Bringer Consulting, a consultancy firm helping biotech executives (CEO, CFO …) to improve the efficiency of their communication with capital market
His experience spans Investor Relations, M&A / in-licensing, external communication, business planning, marketing & sales etc., always in the pharma sector. Hi focus is always to combine a deep understanding of the science and a simplification for appropriate external communication.